No Data
Noil Immune --- For the fiscal year ending December 2024, the in-house drug development business and the joint pipeline will continue to be promoted.
Noil Immune Biotech <4893> announced its financial results for the fiscal year ending December 2024 on the 14th. Business revenue was 0.007 billion yen (compared to 0.316 billion yen in the previous term), operating loss was 1.069 billion yen (compared to a loss of 0.775 billion yen in the previous term), recurring loss was 0.962 billion yen (compared to a loss of 1.127 billion yen in the previous term), and net loss for the year was 0.964 billion yen (compared to a loss of 1.13 billion yen in the previous term). As for the company's business status for the fiscal year, the self-developed drug discovery business based on PRIME technology and the joint pipeline will continue.
Ono's TGCT Therapy Wins FDA Approval, Challenging Daiichi Sankyo
The Nikkei average rose by 497 yen for a significant three-day consecutive gain, after the Buy orders have subsided, it is somewhat heavy on the upside = afternoon of the 13th.
On the 13th, the Nikkei average stock price rose significantly by 497.77 yen to 39,461.47 yen, continuing to rise for three consecutive days. The TOPIX (Tokyo Stock Price Index) increased by 32.26 points to 2,765.59 points. On the 12th, US Stocks showed mixed results with the Dow Inc falling for the first time in three days while the Nasdaq Composite Index rebounded. However, the Nikkei average started with buying pressure due to the depreciation of the yen. After the initial surge in buying, there were some instances of resistance at higher prices, but as the afternoon session began, it showed a strong upward trend.
The Nikkei Average is up around 445 yen, showing steady movement due to the weak yen and rising U.S. stock Index ETF futures in after-hours trading = 13 days before lunch.
On the 13th at around 10:02 AM, the Nikkei average Stocks was trending approximately 445 yen higher at around 39,410 yen. At 9:49 AM, it reached a high of 39,435 yen and 89 sen, an increase of 472 yen and 19 sen. In the US stock market on the 12th local time, the Dow Inc fell for the first time in three days while the Nasdaq Index ETF rebounded, showing mixed developments as it did on the 11th. Due to the rise in the US January CPI (Consumer Price Index), the depreciation of the yen progressed in the Tokyo market as trading ended yesterday on the 12th.
Due to concerns about the outlook of Trump's tariffs, there is a heavy upper trend.
The Nikkei average continued to rise, closing at 38,963.70 yen, up 162.53 yen (Volume estimated at approximately 2.4 billion 60 million shares). Buying started to lead, particularly in high-priced stocks, and the Nikkei average extended its highs to 39,102.65 yen shortly after trading began. However, nearing the 25-day line (39,164 yen), the weight of the prices became apparent, and amid lingering caution over the tariff policy from President Trump, a mood of deferred buying gradually spread, leading the Nikkei average to drop to 38,794 shortly after the start of the afternoon session.
Today's flows: 02/12 Sony Group saw an inflow of JPY¥ 12.93 billion, Nippon Telegraph & Telephone saw an outflow of JPY¥ 6.14 billion
On February 12th, the TSE Main Market saw an inflow of JPY¥ 951.52 billion and an outflow of JPY¥ 949.2 billion.$Sony Group(6758.JP)$, $Fujikura(5803.JP)$ and $Advantest(6857.JP)$ were net buyers of
